These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 37657124)
101. Probing for congenital nasolacrimal duct obstruction. Petris C; Liu D Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011109. PubMed ID: 28700811 [TBL] [Abstract][Full Text] [Related]
102. Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases. Abella R; Varrica A; Satriano A; Tettamanti G; Pelissero G; Gavilanes AD; Zimmermann LJ; Vles HJ; Strozzi MC; Pluchinotta FR; Gazzolo D CNS Neurol Disord Drug Targets; 2015; 14(1):12-23. PubMed ID: 25613500 [TBL] [Abstract][Full Text] [Related]
103. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Hummel J; Rücker G; Stiller B Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011312. PubMed ID: 28770972 [TBL] [Abstract][Full Text] [Related]
104. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease. Hummel J; Rücker G; Stiller B Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011312. PubMed ID: 28262914 [TBL] [Abstract][Full Text] [Related]
105. Biomarkers of cerebral injury in cardiac surgery. Yuan SM Anadolu Kardiyol Derg; 2014 Nov; 14(7):638-45. PubMed ID: 25163078 [TBL] [Abstract][Full Text] [Related]
106. Effects of cerebral near-infrared spectroscopy on the outcome of patients undergoing cardiac surgery: a systematic review of randomised trials. Serraino GF; Murphy GJ BMJ Open; 2017 Sep; 7(9):e016613. PubMed ID: 28882917 [TBL] [Abstract][Full Text] [Related]
107. Impact of perinatal management on neurodevelopmental outcomes in congenital heart disease. Sethi N; Carpenter JL; Donofrio MT Semin Perinatol; 2022 Jun; 46(4):151582. PubMed ID: 35418321 [TBL] [Abstract][Full Text] [Related]
108. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Cantinotti M; Law Y; Vittorini S; Crocetti M; Marco M; Murzi B; Clerico A Heart Fail Rev; 2014 Nov; 19(6):727-42. PubMed ID: 24473828 [TBL] [Abstract][Full Text] [Related]
109. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease. Checchia PA; Paes B; Bont L; Manzoni P; Simões EA; Fauroux B; Figueras-Aloy J; Carbonell-Estrany X Infect Dis Ther; 2017 Mar; 6(1):37-56. PubMed ID: 28070870 [TBL] [Abstract][Full Text] [Related]
110. Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Sanders RD; Nicholson A; Lewis SR; Smith AF; Alderson P Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD009971. PubMed ID: 23824754 [TBL] [Abstract][Full Text] [Related]
111. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults. Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003 [TBL] [Abstract][Full Text] [Related]